OPKO Health, Inc. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
OPK Nasdaq 8071 www.opko.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for OPKO Health, Inc.

Here's Why You Should Retain OPK Stock in Your Portfolio for Now - May 21st, 2026 10:23 am
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies - May 12th, 2026 6:00 am
Spotlight On Promising Penny Stocks For May 2026 - May 11th, 2026 12:05 pm
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China - Apr 30th, 2026 6:30 am
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform - Apr 30th, 2026 6:00 am
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y - Apr 29th, 2026 10:58 am
OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... - Apr 29th, 2026 1:09 am
OPKO Health Q1 Earnings Call Highlights - Apr 28th, 2026 5:39 pm
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates - Apr 28th, 2026 5:00 pm
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Apr 28th, 2026 5:00 pm
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results - Apr 28th, 2026 2:05 pm
How The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price Target - Apr 23rd, 2026 12:04 pm
Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Apr 23rd, 2026 10:07 am
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas - Apr 22nd, 2026 6:00 am
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 - Apr 21st, 2026 2:05 pm
OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 Treatment - Apr 14th, 2026 3:55 am
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19 - Apr 8th, 2026 6:00 am
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates - Mar 27th, 2026 2:05 pm
How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Mar 27th, 2026 12:08 pm
Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy - Mar 20th, 2026 4:08 pm